Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 7 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
NanoBiotech from Diepenbeek, company number BE1023651490, closed financial year 2025 with a result of € -31,644 after tax. For that financial year NanoBiotech recorded a gross margin of € -31,193 and equity of € -26,144. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 10, 2026.
€ -26,144
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -31,644
Profit after tax over the fiscal year.
€ 31
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -31,644.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6
Supplier invoices still open on the last day of the fiscal year.
€ 4,016
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to NanoBiotech?
What happened at NanoBiotech in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 31,644. filed late Source: NBB ↗
- New establishment in Diepenbeek. KBO
- Start of the company according to the CBE. KBO
A new publication or filing at NanoBiotech? We notify you, reason included.
Follow NanoBiotechDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Agoralaan Abis
3590 Diepenbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →Clinitude
€ 419,430 gross margin · 2025
FOx Biosystems
€ -763,895 gross margin · 2023
Highstar Engineering
€ -41,079 gross margin · 2024
IDEA FAMILY
€ -3,258 gross margin · 2025
BIOKEY
€ -25,987 gross margin · 2025
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1023.651.490
- VAT number
- BE 1023.651.490
- Registered office
- Agoralaan Abis, 3590 Diepenbeek
- Names & denominations
- NanoBiotech
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 May 2025
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied